0001013857-21-000084.txt : 20210409 0001013857-21-000084.hdr.sgml : 20210409 20210409161314 ACCESSION NUMBER: 0001013857-21-000084 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20210401 FILED AS OF DATE: 20210409 DATE AS OF CHANGE: 20210409 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Akgonul Rifat Kerim CENTRAL INDEX KEY: 0001855325 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11859 FILM NUMBER: 21817983 MAIL ADDRESS: STREET 1: ONE ROGERS STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PEGASYSTEMS INC CENTRAL INDEX KEY: 0001013857 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374] IRS NUMBER: 042787865 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE ROGERS STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142-1209 BUSINESS PHONE: 6173749600 MAIL ADDRESS: STREET 1: ONE ROGERS STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142-1209 3 1 wf-form3_161799917797654.xml FORM 3 X0206 3 2021-04-01 0 0001013857 PEGASYSTEMS INC PEGA 0001855325 Akgonul Rifat Kerim C/O PEGASYSTEMS INC. ONE ROGERS STREET CAMBRIDGE MA 02142 0 1 0 0 Chief Product Officer Common stock 46909 D Restricted Stock Units 0.0 2018-03-02 Common stock 1478.0 D Restricted Stock Units 0.0 2019-03-05 Common stock 2728.0 D Restricted Stock Units 0.0 2020-03-06 Common stock 3981.0 D Restricted Stock Units 0.0 2021-03-03 Common stock 5350.0 D Restricted Stock Units 0.0 2022-03-02 Common stock 1125.0 D Restricted Stock Units 0.0 2022-03-02 Common stock 4611.0 D Stock Options 25.2 2017-03-09 2026-03-09 Common stock 6177.0 D Stock Options 44.3 2018-03-02 2027-03-02 Common stock 15534.0 D Stock Options 58.95 2019-03-05 2028-03-05 Common stock 21954.0 D Stock Options 64.35 2020-03-06 2029-03-06 Common stock 22595.0 D Stock Options 90.05 2021-03-03 2030-03-03 Common stock 26502.0 D Stock Options 130.45 2022-03-02 2031-03-02 Common stock 15772.0 D Each restricted stock unit represents the right to receive, following vesting, one share of the issuer's common stock. The original grant was 7,387 restricted stock units, with 20% vesting on March 2, 2018, and the remaining 80% vesting in equal quarterly installments over the remaining four years. Once vested, the shares of common stock are not subject to expiration. The original grant was 6,819 restricted stock units, with 20% vesting on March 5, 2019, and the remaining 80% vesting in equal quarterly installments over the remaining four years. The original grant was 6,635 restricted stock units, with 20% vesting on March 6, 2020, and the remaining 80% vesting in equal quarterly installments over the remaining four years. The original grant was 6,687 restricted stock units, with 20% vesting on March 3, 2021, and the remaining 80% vesting in equal quarterly installments over the remaining four years. Represents election by the individual, as part of the Company's Corporate Incentive Plan (CICP), to receive half of their annual bonus in RSUs, based upon the Company's stock price as of March 2, 2021. All RSUs vest 100% on March 2, 2022, subject to attainment of the CICP performance threshold funding for the year ending December 31, 2021. RSUs will vest 20% on March 2, 2022, with the remaining 80% vesting in equal quarterly installments over the remaining four years. The original grant was 30,883 options, with 20% vesting on March 9, 2017, with the remaining 80% vesting in equal quarterly amounts over the next four years. The original grant was 24,382 options, with 20% vesting on March 2, 2018, with the remaining 80% vesting in equal quarterly amounts over the next four years. Options vested 20% on March 5, 2019, with the remaining 80% vesting in equal quarterly amounts over the next four years. Options vested 20% on March 6, 2020, with the remaining 80% vesting in equal quarterly amounts over the next four years. Options vested 20% on March 3, 2021, with the remaining 80% vesting in equal quarterly amounts over the next four years. Options will vest 20% on March 2, 2022, with the remaining 80% vesting in equal quarterly installments over the remaining four years. Rifat Kerim Akgonul became Pegasystems Inc.'s Chief Product Officer effective April 1, 2021. EXHIBIT LIST: EX-24 RKAkgonul Ex. 24 /s/ Donald L. Lancaster, Attorney-in-Fact for Rifat Kerim Akgonul 2021-04-07 EX-24 2 poarkakgonul.htm RKAKGONUL EX. 24

POWER OF ATTORNEY
For Executing Forms 3, 4 and 5

The undersigned hereby constitutes and appoints each of Matthew J. Cushing, Donald L. Lancaster, and Jenna L. Burstyn, signing singly,
as the undersigned's true and lawful attorney-in-fact to:

(1) execute for and on behalf of the undersigned, in the undersigned's capacity as an officer and/or director of Pegasystems Inc. (the "Company"), Forms 3, 4 and 5 (including any amendments thereto) in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and the rules thereunder; and

(2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete the execution of any such Forms 3, 4 and 5 and the timely filing of such forms with the United States Securities and Exchange Commission (the "SEC") and any other authority; and

(3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in his or her discretion.

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform all and every act and thing whatsoever requisite, necessary and proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or his or her substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted.  The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's liabilities or responsibilities to comply with Section 16 of the Exchange Act.

This Power of Attorney replaces in their entirety any and all prior powers of attorney executed by the undersigned with respect to the subject matters set forth herein, including any powers of attorney previously filed with the SEC, which prior powers of attorney are hereby revoked in their entirety.  This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed this 26th day of March, 2021.



Signed:/s/ Rifat Kerim Akgonul
RIFAT KERIM AKGONUL
Chief Product Officer